You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antibody

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hidradenitis Suppurativa Trial in Worldwide (Bermekimab, Adalimumab, Placebo)

Recruiting
  • Hidradenitis Suppurativa
  • Glendale, Arizona
  • +71 more
Aug 2, 2022

Effect of Drugs Trial in Nanjing (Sintilimab)

Completed
Has Results
  • Effect of Drugs
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Hospital
Dec 20, 2020

HER2-positive Breast Cancer Trial in Iran, Islamic Republic of (Trastuzumab, Pertuzumab, Carboplatin)

Completed
  • HER2-positive Breast Cancer
  • Rasht, Guilan, Iran, Islamic Republic of
  • +43 more
Aug 31, 2021

Renal Cell Carcinoma, Kidney Cancer Trial in Minneapolis, Cleveland (Durvalumab, Tremelimumab)

Completed
  • Renal Cell Carcinoma
  • Kidney Cancer
  • Minneapolis, Minnesota
  • +1 more
Dec 21, 2020

Hepatitis B Trial in Germany (Engerix-B™ Kinder)

Completed
Has Results
  • Hepatitis B
  • Engerix-B™ Kinder
  • Bad Saulgau, Baden-Wuerttemberg, Germany
  • +11 more
Apr 27, 2018

Eosinophilic Gastritis, Eosinophilic Duodenitis Trial in United States (lirentelimab)

Enrolling by invitation
  • Eosinophilic Gastritis
  • Eosinophilic Duodenitis
  • Gilbert, Arizona
  • +24 more
Jan 6, 2021

Gastric or Gastroesophageal Junction Adenocarcinoma Trial in China (JS001/Placebo, JS001/ combine with Postoperative Adjuvant

Recruiting
  • Gastric or Gastroesophageal Junction Adenocarcinoma
  • JS001/Placebo
  • JS001/placebo combine with Postoperative Adjuvant Chemotherapy
  • Bengbu, Anhui, China
  • +53 more
Jul 28, 2022

T Lymphoblastic Leukemia/Lymphoma, Extramedullary NK-T-cell Lymphoma, Nasal Type, Peripheral T-cell Lymphoma, Nonspecific Trial

Recruiting
  • T Lymphoblastic Leukemia/Lymphoma
  • +6 more
  • T cell injection targeting CD7 chimeric antigen receptor
  • Zhengzhou, Henan, China
    First Affiliated Hospital of Zhengzhou University
Jan 4, 2021

Malignant Melanoma Trial in New York, Oxford, Glasgow (IMCgp100)

Terminated
Has Results
  • Malignant Melanoma
  • New York, New York
  • +2 more
Jul 1, 2020

Bone Metastases Trial in Shanghai (Anti-RANKL Monoclonal Antibody)

Unknown status
  • Bone Metastases
  • Anti-RANKL Monoclonal Antibody
  • Shanghai, China
    Shanghai East Hospital
May 27, 2018

Hodgkin Lymphoma Trial in Saint Petersburg, Irkutsk (Nivolumab, Ifosfamide, Carboplatin)

Recruiting
  • Hodgkin Lymphoma
  • Saint Petersburg, Pesochny, Russian Federation
  • +2 more
Jul 19, 2021

Immunization; Infection Trial in Karachi (Conditional Cash Transfer, SMS Reminder)

Completed
  • Immunization; Infection
  • Conditional Cash Transfer
  • SMS Reminder
  • Karachi, Sindh, Pakistan
    BHU 51-B
Jul 27, 2020

Diffuse Large B-cell Lymphoma Trial in China (Zanubrutinib)

Completed
Has Results
  • Diffuse Large B-cell Lymphoma
  • Beijing, Beijing, China
  • +10 more
Oct 11, 2021

NSCLC Trial in China

Recruiting
  • Non-small Cell Lung Cancer
    • Hangzhou, Zhejiang, China
    • +7 more
    Dec 31, 2020

    Eosinophilic Gastritis, Eosinophilic Duodenitis Trial in United States (AK002, Placebo)

    Recruiting
    • Eosinophilic Gastritis
    • Eosinophilic Duodenitis
    • Birmingham, Alabama
    • +73 more
    Dec 9, 2021

    Glioma Microenvironment and Function and Visualization of

    Recruiting
    • Glioma
    • surgery
    • Shanghai, China
      Huashan Hospital，Fudan University
    Mar 22, 2021

    NSCLC Trial in Worldwide (Durvalumab, Placebo, Osimertinib (single-arm, open-label))

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Tuscaloosa, Alabama
    • +260 more
    Dec 16, 2022

    Recurrent Respiratory Papillomatosis, Human Papilloma Virus Trial in United Kingdom (Microdebrider, Cold-steel surgery

    Recruiting
    • Recurrent Respiratory Papillomatosis
    • Human Papilloma Virus
    • Microdebrider
    • +9 more
    • Aberdeen, United Kingdom
    • +47 more
    Jan 10, 2022

    Non-Hodgkin's Lymphoma Trial in Japan (bendamustine HCl)

    Completed
    • Non-Hodgkin's Lymphoma
    • bendamustine hydrochloride
    • Kanagawa, Japan
    • +3 more
    Oct 19, 2020

    Clostridium Difficile Infection Trial (MK-6072, MK-3415A, Placebo)

    Completed
    Has Results
    • Clostridium Difficile Infection
    • MK-6072
    • +3 more
    • (no location specified)
    Aug 6, 2018

    Colorectal Cancer, Breast Cancer, Pancreas Cancer Trial in Seongnam-si, Seoul (SNB-101)

    Unknown status
    • Colorectal Cancer
    • +6 more
    • Seongnam-si, Gyeonggi-do, Korea, Republic of
    • +2 more
    Feb 15, 2021

    Biliary Tract Cancer Trial in Riyadh (FOLFIRINOX)

    Recruiting
    • Biliary Tract Cancer
    • FOLFIRINOX
    • Riyadh, Saudi Arabia
      king Faisal Specialist Hospital and Research Center
    Aug 30, 2021

    Coordinated Programme to Prevent Arthritis - Can We Identify

    Recruiting
    • Inflammatory Arthritis
    • Rheumatoid Arthritis
      • Leeds, West Yorkshire, United Kingdom
        Chapel Allerton Hospital : Leeds Institute of Rheumatic and Musc
      Mar 3, 2021

      Squamous NSCLC Trial in Italy (Nivolumab 10 MG/ML Intravenous Solution, Best Supportive Care)

      Active, not recruiting
      • Squamous Non-small Cell Lung Cancer
      • Nivolumab 10 MG/ML Intravenous Solution
      • Best Supportive Care
      • Imola, Bologna, Italy
      • +30 more
      Sep 30, 2022

      Epstein-Barr Virus Positive, Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma Trial (Durvalumab,

      Withdrawn
      • Epstein-Barr Virus Positive
      • +6 more
      • (no location specified)
      Oct 22, 2020